FY2025 Earnings Forecast for OTCMKTS:GTBIF Issued By Cormark

Key Points

• Investment analysts at Cormark have lowered their FY2025 earnings per share estimate for Green Thumb Industries to $0.06, down from $0.10.
• Despite the earnings forecast decrease, Benchmark has maintained a "buy" rating on Green Thumb Industries.
• Green Thumb Industries reported a quarterly earnings loss of ($0.01) per share, missing the consensus estimate of $0.04, but exceeded revenue expectations with $293.26 million for the quarter.

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Investment analysts at Cormark reduced their FY2025 earnings per share estimates for shares of Green Thumb Industries in a note issued to investors on Monday, August 11th. Cormark analyst J. Pytlak now anticipates that the company will post earnings of $0.06 per share for the year, down from their prior estimate of $0.10. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share.

Separately, Benchmark reaffirmed a "buy" rating on shares of Green Thumb Industries in a research note on Monday.

Green Thumb Industries Stock Performance

OTCMKTS:GTBIF opened at $8.50 on Tuesday. The stock has a 50 day moving average price of $5.76 and a 200 day moving average price of $5.99. The stock has a market cap of $1.80 billion, a PE ratio of 77.28 and a beta of 1.18. Green Thumb Industries has a one year low of $4.63 and a one year high of $12.00.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). Green Thumb Industries had a return on equity of 1.62% and a net margin of 2.51%. The firm had revenue of $293.26 million during the quarter, compared to analyst estimates of $280.66 million.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.